Get notified when CRWD files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsQ1 FY27: Returns to profit on 26% revenue growth, $1.39B M&A spend, buyback
Filed June 4, 2026 · Period ending April 30, 2026 · Compared to 10-Q Jun 4, 2025 · ~1 min read
Key Changes
-
high
Net income of $27.8M (2% margin) vs. $110.2M loss in Q1 FY26, driven by operating leverage, lower July 19 Incident costs ($20.5M reduction), and $36.4M higher investment gains.
MD&A: Financial Results verify on EDGAR → -
high
Changed commission amortization estimate from 4 to 5 years, reducing Q1 FY27 sales expense by $27.9M—a material benefit to operating margins.
MD&A: Commission Estimate Change verify on EDGAR → -
high
Spent $881.4M on Seraphic and SGNL acquisitions in Q1 FY27, signaling aggressive platform expansion; repurchased $175.6M of stock, a new capital allocation activity.
MD&A: Cash Flows verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (IREN 10-K) is open in full — no account needed.
Partner
Trade CRWD commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 21, 2026 · How we verify